Assessment of cardiovascular risk and simultaneous treatment of multiple risk factors is important in patients with metabolic syndrome

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 9, 2008-09 ,pp. : 13-17

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issues: Managing the Cardiovascular Risk Associated with the Metabolic Syndrome)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 4941-4943

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Assessment, Genetic Testing, and Management of Lynch Syndrome

By Grover Shilpa   Syngal Sapna  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 8, Iss. 1, 2010-01 ,pp. : 98-105

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Prevalence of the Metabolic Syndrome: Impact on Cardiovascular Risk Epidemiology – A Population-Based Study from Malmö, Sweden

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 273-278

Karger

Access to resources Recommend Favorite